Semler Scientific

Monarch Medical Technologies is a medical technology company that specializes in providing advanced computer-based solutions for healthcare institutions, focusing on glycemic management. Its flagship product, the EndoTool Glucose Management System, offers a technology-enabled approach to managing blood glucose levels, replacing traditional manual dosing methods with a user-friendly software application that integrates with major electronic medical record systems. This FDA-cleared system is designed to enhance patient-specific glycemic control across various patient populations, including those with complex conditions such as sepsis and diabetic ketoacidosis. Additionally, Monarch Medical Technologies offers EndoTool Analytics, a reporting tool that helps healthcare organizations identify and analyze performance trends related to glycemic control, clinician compliance, and areas for improvement. The company is based in the United States and also provides clinical consulting services to support its clients in achieving optimal glycemic management outcomes.

Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.